We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Moleculin Biotech Inc | TG:MOL | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
BUDAPEST--Hungarian oil and gas company MOL Nyrt.'s (MOL.BU) unit MOL Kalegran Ltd., the operator of the Akri-Bijeel block, said Thursday that it has agreed upon its field development plan with the Kurdish Ministry of Natural Resources.
MAIN FACTS:
--The field development plan relates to two commercial discovery areas in the Akri-Bijeel block, the Bijell and the Bakrman areas.
--The two-phase development program approved on Thursday will allow MOL Kalegran to best determine key factors such as the recovery factor.
--An extended well testing facility with 10 mboepd capacity is already producing without any disruption on the Bijell area and the Operator intends to add further temporary, rented facilities to ramp up production from both areas to 35 mboepd in 2015.
--Following the determination of the required amount of wells and other infrastructure, which will include an export pipeline and central production facility, MOL Kalegran intends to increase production from the block to minimum of 50 mboepd by 2017-2018.
Write to Margit Feher at margit.feher@wsj.com
1 Year Moleculin Biotech Chart |
1 Month Moleculin Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions